Clinical Trial Update: Brivaracetam to Reduce Neuropathic Pain in Chronic Spinal Cord Injury [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial evaluating brivaracetam for reducing neuropathic pain in adults with chronic spinal cord injury has completed, with results posted on 2025-04-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Briviact (brivaracetam)

Snippet

Sponsor: University of Minnesota | Conditions: Spinal Cord Injuries | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-04-27